Für diesen Artikel ist leider kein Bild verfügbar.

Drug–Drug Interactions in Pharmaceutical nt

Li (Autor)

Software / Digital Media
264 Seiten
2007
John Wiley & Sons Inc (Hersteller)
978-0-470-18792-0 (ISBN)
103,41 inkl. MwSt
  • Keine Verlagsinformationen verfügbar
  • Artikel merken
Reviews relevant science, industrial practice, and regulatory agency positions on drug drug interactions. This title focuses on the evaluation of potential drug drug interactions, allowing researchers to address risk factors before a drug is put to market. It covers both clinical and nonclinical aspects for understanding drug drug interactions.
"Drug Drug Interactions in Pharmaceutical Development" comprehensively reviews the relevant science, industrial practice, and regulatory agency positions on drug drug interactions. It focuses on the evaluation of potential drug drug interactions, allowing researchers to address risk factors before a drug is put to market. The book covers both clinical and nonclinical aspects for understanding drug drug interactions as well as in vitro and in vivo studies for use in studying interactions at the drug discovery stage.

Albert P. Li is the President and CEO of In Vitro ADMET Laboratories, LLC (www.invitroadmet.com), and Advanced Pharmaceutical Sciences, Inc. (www.apsciences.com), and the cofounder, Chairman, and CSO of the ADMET Group (www.admetgroup.com). Dr. Li has over twenty-five years in the drug development industry, is a distinguished international speaker in the field, and has over 150 publications. He has edited several books.

Erscheint lt. Verlag 1.11.2007
Verlagsort New York
Sprache englisch
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Pharmakologie / Pharmakotherapie
ISBN-10 0-470-18792-1 / 0470187921
ISBN-13 978-0-470-18792-0 / 9780470187920
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich